Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Eli Lilly verifies disclosure of clinical trial data as promised through third-party audit
August 18th, 2006
An independent, third-party audit firm has confirmed that Eli Lilly and Company (LLY) has followed through on its commitment to post clinical trial information on its Web site. The registry is an extension of the company's Principles of Medical Research, which were adopted by Lilly in 2003. These principles are an outline of policies and codes for the conduct of medical research, disclosure of research results, and payment to investigators for services related to the conducting of clinical trials. When Lilly launched its clinical trial registry, www.lillytrials.com, in December 2004, it was one of the first pharmaceutical companies to voluntarily...
Source: Biotech Law Weekly (2006-08-18)
|
